Anti-Androgen Therapy in Polyendocrine Metabolic Ovary Syndrome (PMOS, Formerly PCOS): Efficacy, Safety, and Phenotype-Oriented Clinical Decision-Making
July 2026
in “
Journal of Ovarian Research
”
anti-androgen therapy polyendocrine metabolic ovarian syndrome PMOS polycystic ovary syndrome PCOS hyperandrogenism combined oral contraceptives spironolactone cyproterone acetate finasteride insulin sensitizers metformin cardiovascular safety predictive biomarkers birth control pills Aldactone Androcur Propecia Glucophage
Studysummary In this review, researchers provided a comprehensive analysis of anti-androgen therapies for polyendocrine metabolic ovarian syndrome (PMOS/PCOS), examining their efficacy and safety while proposing a phenotype-guided management framework and highlighting research gaps, such as long-term cardiovascular safety and predictive biomarkers.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer